Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 48,445 | 14,416 | 11,599 | 57,367 | 77,498 |
| Gross Profit | 48,445 | 14,416 | 11,599 | 57,367 | 77,498 |
| Operating Expenses | 12,851 | 10,742 | 9,896 | 8,806 | 7,288 |
| Operating Income | 35,594 | 3,674 | 1,703 | 48,561 | 70,210 |
| Interest Expense | 12 | 2 | 2 | 2 | 2 |
| Other Income | 341 | 511 | 289 | 212 | 303 |
| Pre-tax Income | 35,923 | 4,183 | 1,990 | 48,771 | 70,511 |
| Income Tax | 9,734 | -1,629 | -428 | 20,018 | 28,502 |
| Net Income Continuous | 26,189 | 5,812 | 2,418 | 28,753 | 42,009 |
| Net Income | $26,189 | $5,812 | $2,418 | $28,753 | $42,009 |
| EPS Basic Total Ops | 1.39 | 0.30 | 0.13 | 1.54 | 2.26 |
| EPS Basic Continuous Ops | 1.39 | 0.30 | 0.13 | 1.54 | 2.26 |
| EPS Diluted Total Ops | 1.36 | 0.29 | 0.13 | 1.49 | 2.18 |
| EPS Diluted Continuous Ops | 1.36 | 0.30 | 0.13 | 1.49 | 2.18 |
| EBITDA(a) | $36,495 | $4,471 | $2,487 | $49,263 | $70,810 |